Affiliation:
1. Department of Microbiology, Assam University , Silchar, Cachar, Assam 788011 , India
2. Department of Microbiology, Silchar Medical College and Hospital , Silchar, Cachar, Assam 788014 , India
Abstract
Abstract
Aims
Carbapenem-resistant Escherichia coli has been categorized as a pathogen of critical priority by the World Health Organization as it is highly infectious with high mortality and morbidity rates and widespread transmission potential. Carbapenem resistance is primarily mediated by carbapenemase-encoding genes and, additionally, through intrinsic factors. In India, over the years, carbapenemase-encoding genes have been reported from diverse clinically significant pathogens. The present study identifies E. coli of clinical origin that harbours blaOXA-144.
Methods and results
The study isolate was obtained from a tertiary referral hospital in northeast India. Carbapenemase production was investigated through culture on chromogenic agar and Rapidec Carba NP test as per manufacturer’s instructions. Susceptibility of the isolate was performed by the Kirby–Bauer disc diffusion method and agar dilution method following CLSI guidelines. PCR targeting carbapenemase-encoding genes was performed, followed by transformation and conjugation experiments. Whole-genome sequencing of the isolate was done through the Illumina sequencing platform and the data were analysed using the Centre for Genomic Epidemiology database. BJD_EC180 is 6 919 180 bp in length and consists of six rRNA operons, 111 tRNA, and 6849 predicted protein-coding sequences. BJD_EC180 belonged to ST2437 and harboured the carbapenemase-encoding gene blaOXA-144 with ISAba1 upstream, along with multiple antibiotic resistance genes conferring clinical resistance towards beta-lactams, aminoglycosides, amphenicols, sulphonamides, tetracyclines, trimethoprim, and rifampin.
Conclusions
Carbapenem-resistant E. coli harbouring blaOXA-144 associated with insertion sequence pose a serious health threat as their mobilization into carbapenem non-susceptible strains that will contribute to the resistance burden and therefore, needs urgent monitoring.
Funder
DBT
NER
Indian Council of Medical Research
SRF
Publisher
Oxford University Press (OUP)
Reference41 articles.
1. Diversity in Acinetobacter baumannii isolates from paediatric cancer patients in Egypt;Al-Hassan;Clin Microbiol Infect,2013
2. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing;Bankevich;J Comput Biol,2012
3. Carbapenemase-producing organisms: a global scourge;Bonomo;Clin Infect Dis,2018
4. MeDuSa: a multi-draft based scaffolder;Bosi;Bioinformatics,2015
5. Prevalence, genotyping of Escherichia coli and Pseudomonas aeruginosa clinical isolates for Oxacillinase resistance and mapping susceptibility behaviour;Chaudhary,2014